Solid Biosciences (SLDB)
(Delayed Data from NSDQ)
$8.06 USD
+0.34 (4.40%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $8.12 +0.06 (0.74%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.66 |
EPS Last Quarter | -0.64 |
Last EPS Surprise | -12.28% |
ABR | 1.40 |
Earnings ESP
|
-1.65% |
---|---|
Current Year | -2.65 |
Next Year | -2.60 |
EPS (TTM) | -3.94 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.40M | 4.40M | 17.60M | 17.70M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 4.40M | 4.40M | 17.60M | 17.70M |
Low Estimate | 4.40M | 4.40M | 17.60M | 17.70M |
Year ago Sales | 0.00M | 0.00M | 8.09M | 17.60M |
Year over Year Growth Est. | NA | NA | 117.45% | 0.57% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.66 | -0.69 | -2.65 | -2.60 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.72 | -0.78 | -2.58 | -3.63 |
High Estimate | -0.56 | -0.61 | -2.34 | -1.34 |
Low Estimate | -0.72 | -0.78 | -2.87 | -3.63 |
Year ago EPS | -1.25 | -1.05 | -4.83 | -2.65 |
Year over Year Growth Est. | 47.20% | 34.29% | 45.13% | 1.78% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 2 | 2 | 2 |
Up Last 60 Days | 0 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 2 | 4 | 3 |
Down Last 60 Days | 4 | 2 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.66 | -0.69 | -2.65 | -2.60 |
7 Days Ago | -0.66 | -0.69 | -2.65 | -2.60 |
30 Days Ago | -0.61 | -0.66 | -2.64 | -2.48 |
60 Days Ago | -0.61 | -0.66 | -2.64 | -2.48 |
90 Days Ago | -0.91 | -0.86 | -3.46 | -1.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.67 | -0.70 | -2.70 | -2.64 |
Zacks Consensus Estimate | -0.66 | -0.69 | -2.65 | -2.60 |
Earnings ESP | -1.65% | -1.32% | -1.93% | -1.46% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.64 | -1.00 | -1.05 | -1.25 | NA |
Estimate | -0.57 | -1.01 | -1.20 | -1.52 | NA |
Difference | -0.07 | 0.01 | 0.15 | 0.27 | 0.09 |
Surprise | -12.28% | 0.99% | 12.50% | 17.76% | 4.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more